TrialSignal
Clinical trial intelligence report
STABICAN : Measurement of Implant Stability by Analysis of the Resonance Frequency in Patients Treated for Cancer of the Upper Aero-digestive Tract
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04532359-Jul 28, 2026
NCT ID
NCT04532359
Status
UNKNOWN
Phase
registry-stage
Sponsor
Centre Leon Berard
Executive brief
Investment-Ready Snapshot
STABICAN : Measurement of Implant Stability by Analysis of the Resonance Frequency in Patients Treated for Cancer of the Upper Aero-digestive Tract is a registry-stage clinical asset sponsored by Centre Leon Berard in Cancer. SEO and diligence focus: Implant placement, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04532359
Indication
Cancer
Modality
medical device
Target
Implant placement
Intervention
Implant placement
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.